Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of DS-1971a by Age, Gender, and Race
NCT02261376Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of DS-1971 in Peripheral neuropathic pain (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Pharmacokinetic Profile of DS-1971a at 4 days. Started Sep 2014; status: completed.
02
Drugs
DS-1971
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02261376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261376.